This study is designed to evaluate the pharmacokinetic and pharmacodynamic characteristics of indobufen in healthy subjects.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
12
Single Oral Dose of
Pusan National University Yangsan Hospital
Pusan, South Korea
RECRUITINGAsan Medical Center
Seoul, South Korea
RECRUITINGPharmacokinetics
AUC, Cmax
Time frame: 24 Hours
Pharmacodynamics
Platelet Aggregation Test
Time frame: 24 Hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.